Quantcast

Frost & Sullivan Award Underlines Siemens Healthcare’s Contribution to New Product Innovation in the North American Medical Imaging Market

July 13, 2011

MOUNTAIN VIEW, Calif., July 13, 2011 /PRNewswire/ — Based on its recent analysis of the medical imaging market, Frost & Sullivan recognizes Siemens Healthcare with the 2011 North American Frost & Sullivan Award for New Product Innovation. Siemens Healthcare’s innovative Biograph mMR is the first scanner capable of simultaneously acquiring whole-body positron emission tomography (PET) and magnetic resonance imaging (MRI) data.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/frostsullivan/51015/

(Photo: http://photos.prnewswire.com/prnh/20110713/MM31307 )

“While the ability to fuse and spatially register PET and MRI data has been available for several years, no manufacturer has successfully integrated these two modalities into a single-gantry, whole-body scanner,” said Frost & Sullivan research analyst Roberto Aranibar.

Simultaneous acquisition of PET and MRI data reduces overall procedure time by providing PET/MRI in a single scan, thus eliminating any time required for patient transport. Faster procedure times improve the patient experience and enable faster delivery of images to clinicians for review. The collection of MRI attenuation data during diagnostic scanning also reduces procedure time and improves clinical workflow.

With a footprint comparable to a standard, high-field MRI scanner, the Biograph mMR can be sited in existing MRI rooms, eliminating renovation costs for customers seeking to replace an existing MRI.

“The ability to be used in an MR-only capacity, when PET is not clinically indicated, helps keep utilization of the scanner high and the ability to perform PET/MRI within the timeframe of a typical MRI procedure helps maximize patient throughput and maintain good clinical workflow,” said Aranibar.

Based on its imaging characteristics and capabilities, PET/MRI is initially expected to find the strongest interest among clinicians and researchers in neurology, oncology, cardiology and pediatric imaging.*

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in the following categories: innovative element of the product, leverage of leading edge technologies, value added features/benefits, increased customer ROI and customer acquisition/penetration potential.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry.

*MR scanning has not been established as safe for imaging fetuses and infants under two years of age. The responsible physician has to decide about the benefit of the MRI examination in comparison to other imaging procedures.

About Siemens Healthcare

The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2010 (to September 30), the Sector posted revenue of 12.4 billion euros and profit of around 750 million euros. For further information please visit: www.siemens.com/healthcare

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.awards.frost.com.

SOURCE Frost & Sullivan


Source: newswire



comments powered by Disqus